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Summary
 
Mice rendered deficient in CD28 signaling by the soluble competitor, cytotoxic T lympho-
cyte–associated molecule 4–immunoglobulin G1 fusion protein (CTLA4-Ig), fail to upregulate
OX40 expression in vivo
 
 
 
or form germinal centers
 
 
 
after
 
 
 
immunization. This is associated with
impaired interleukin 4 production and a lack of CXC chemokine receptor (CXCR)5 on CD4
T cells, a chemokine receptor linked with migration into B follicles. Germinal center forma-
tion is restored in CTLA4-Ig transgenic mice by coinjection of an agonistic monoclonal anti-
body to CD28, but this is substantially inhibited if OX40 interactions are interrupted by simul-
taneous injection of an OX40-Ig fusion protein. These data suggest that CD28-dependent
OX40 ligation of CD4 T cells at the time of priming is linked with upregulation of CXCR5
expression, and migration of T cells into B cell areas to support germinal center formation.
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S
 
tudies of the timing and location of T and B cell activa-
tion show that the primary site of CD4 cognate help for
B cells is in the outer T zone (1, 2). After this engagement,
two distinct processes evolve. In the first process, activated
B cells migrate to extrafollicular foci where they proliferate
extensively and differentiate into plasma cells (3). Although
the Ab produced is of relatively low affinity, production is
rapid. In the second process, antigen-specific B and T cells
migrate into follicles and form germinal centers (GCs)
 
1
 
where somatic mutation and affinity maturation occur.
Unlike differentiation of plasmablasts in the extrafollicular
foci, the efficient selection of rare B cell mutants in GCs is
highly dependent on the provision of T cell help. Approxi-
mately 10% of lymphocytes in GCs are antigen-specific
CD4 T cells (4), and their deletion leads to the rapid disso-
lution of GCs (5). As a consequence of this process, high-
affinity Ab is produced, albeit relatively slowly.
We have investigated the molecular events that control
T cell help for GCs. A starting point for our studies was the
observation that T cell signaling through CD28 is clearly
important for GC development. CD28-deficient mice lack
GCs and fail to develop class-switched high-affinity Ab (6,
7), and this is linked with selectively poor Th2 develop-
ment in vivo (8) and in vitro
 
 
 
(9). Despite this, CD28-defi-
cient mice make some low-affinity T cell–dependent Ab in
the extrafollicular response, and T cell–independent re-
sponses are normal (7). This implies that CD28 signaling of
CD4 T cells plays a crucial nonredundant role in GC for-
mation.
In vitro
 
 
 
in both humans (10) and mice (11), CD28 co-
stimulation by itself seems to be a poor signal for the pro-
duction of IL-4 in naive CD4 T cells. However, we and
others have recently reported that in mice (11) and humans
(10), costimulation through OX40 and CD28 promotes
IL-4 expression in naive CD4 T cells in vitro. This combi-
nation also upregulates expression of CXC chemokine re-
ceptor (CXCR)5
 
 
 
mRNA (11), linking CD4 T cell IL-4
production with the capacity to migrate into B follicles and
help GC formation. This conclusion is supported by trans-
genic mice that constitutively express OX40 ligand on
dendritic cells (DCs) (CD11c-OX40L tg mice). CD4 T
cells receive a default OX40 signal when they are primed
in these mice, and this is associated with greatly increased
 
1
 
Abbreviations used in this paper:
 
 CD11c-OX40L tg mice, transgenic mice
expressing OX40L driven by the CD11c promoter; CTLA, CTL-associ-
ated molecule; CTLA4-Ig tg mice, transgenic mice expressing the soluble
CD28 competitor, CTLA4-Ig; CXCR, CXC chemokine receptor; DC,
dendritic cell; GC, germinal center; NP, 4-hydroxy-3-nitrophenyl acetyl;
OX40-Ig, murine OX40–human IgG1 fusion protein; OX40L, OX40
ligand.
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numbers of CD4 T cells in splenic B cell areas (12). Taken
together, these experiments strongly implicate OX40 sig-
naling in the migration of CD4 T cells into GCs, and the
development of a cytokine profile conducive for B cell
help.
In this paper, we have examined the interrelationship
between CD28 and OX40 signaling. We report deficient
expression of OX40 and IL-4 in mice that express the solu-
ble CD28 competitor, CTL-associated molecule 4–IgG1
fusion protein (CTLA4-Ig tg mice [7]), and show that
these mice lack an activated subset of CD4 T cells that ex-
press CXCR5. In contrast
 
, 
 
CD11c-OX40L tg mice have
increased numbers of CXCR5
 
1
 
 T cells, but this phenotype
is dependent on CD28 signaling. GC formation is restored
in CTLA4-Ig tg mice by coinjection of agonistic CD28
mAb, but this is substantially dependent on OX40 signal-
ing, as injection of a fusion protein between murine OX40
and human IgG1 (OX40-Ig) inhibits GC development but
not the generation of extrafollicular plasma cell foci. These
experiments reveal that there is a hierarchy of costimula-
tory signals that regulate T cell help for B cell GCs. CD28
signaling is permissive for OX40 signaling that, in addition
to costimulatory effects, is specifically linked with T cell
migration to B cell areas and the formation of GCs.
 
Materials and Methods
 
Preparation and Stimulation of CD4
 
1
 
CD62L
 
high
 
 Cells.
 
CD4
CD62L
 
high
 
 cells were prepared from BALB/c mice aged 6–12 wk
by MACS
 
®
 
 (Miltenyi Biotec), as described elsewhere (11). CD4
T cells which were consistently 
 
.
 
95% pure for CD4 and
CD62L
 
high
 
 expression were activated in 24-well plates (Nunc)
previously coated with 10 
 
m
 
g/ml anti–murine CD3 mAb (2C11;
PharMingen). The cultures were incubated with or without a
10% final concentration of a supernatant of anti-CD28 mAb
(clone 37.51; a gift of Dr. Jim Allison, University of California at
Berkeley, Berkeley, CA).
 
Mice.
 
BALB/c, CD11c-OX40L, and CTLA4-Ig tg experi-
mental animals were bred and maintained in accordance with an-
imal house guidelines.
 
Semiquantitative Reverse Transcription PCR on CTLA4-Ig Tg
Mice and Control Littermates.
 
For in vivo
 
 
 
studies of mRNA
 
 
 
ex-
pression, footpad immunizations were carried out using 50 
 
m
 
g
alum-precipitated chicken 
 
g
 
-globulin resuspended in 200 
 
m
 
l nor-
mal saline, or heat-killed 
 
Bordetella pertussis
 
 (5 
 
3
 
 10
 
8
 
) resuspended
in 200 
 
m
 
l normal saline as indicated. Immunized mice were killed
3 and 7 d after immunization by CO
 
2
 
 asphyxiation. RNA and
cDNA samples were prepared from draining popliteal LNs as de-
scribed (13).
cDNA prepared from the tissue sections was diluted to a final
volume of 100 
 
m
 
l. The PCR 
 
b
 
-actin signal was used to correct
for differences in the amount of starting cDNA from each sam-
ple. The specific primers were: 
 
b
 
-actin (Stratagene), 5
 
9
 
-AGCG-
GGAAATCGTGCGTG and 5
 
9
 
-CAGGGTACATGGTGGT-
GCC; IL-4 (14), 5
 
9
 
-GAATGTACCAGGAGCCATATC and
5
 
9
 
-CTCAGTACTACGAGTAATCCA; IFN-
 
g
 
 (14), 5
 
9
 
-AAC-
GCTACACACTGCATCTTGG and 5
 
9
 
-GACTTCAAAGAG-
TCTGAGG; murine OX40, 5
 
9
 
-TGTATGTGTGGGTTCAG-
CAGCC and 5
 
9
 
-CCCTCAGGAGTCACCAAGGTGGG; and
murine OX40L, 5
 
9
 
-ATGGAAGGGGAAGGGGTTCAACC and
5
 
9
 
-TCACAGTGGTACTTGGTTCACAG.
 
For semiquantitative reverse transcription PCR of OX40,
OX40L, IL-4, and IFN-
 
g
 
 mRNA, 
 
z
 
10 fewer cycles than were
required to detect PCR product using ethidium bromide gels
were performed, so that quantitation could be performed by
PCR Southern blot or Southern dot blot analysis. For each set of
primers, three different numbers of PCR cycles were performed,
to ensure that amplification was logarithmic and that the condi-
tions were not saturating. The PCR product was separated on a
1.5% agarose gel and transferred onto prewetted Hybond-N
 
1
 
membrane (Nycomed Amersham plc) by capillary transfer under
alkaline conditions. The membrane was hybridized with a 
 
32
 
P-
labeled purified PCR product used as a probe and imaged using a
PhosphorImager
 
® 
 
(Molecular Dynamics).
Using ImageQuant
 
®
 
 software (Molecular Dynamics), a grid
was laid over PCR bands with individual fields covering the cen-
tral 50% of a band. The signal in each field was calculated and
these figures transferred to spreadsheet software to sort the ran-
domized files to the correct order. The average of the three
PCRs with different cycle number for each gene was taken and
divided by the average of the three corresponding 
 
b
 
-actin PCRs.
These values represent the relative amount of mRNA for each
gene per cell. This value was multiplied by the size of the section
area (determined by microscopy on adjacent sections to those
taken for cDNA using the point counting technique [15]) to give
mRNA amount per section.
 
Abs.
 
A polyclonal rabbit antiserum prepared by immunizing
with CXCR5
 
 
 
peptides was a gift of Dr. Jason Cyster, University
of California San Francisco, San Francisco, CA (16). The speci-
ficity of this Ab was confirmed in cross-blocking studies with a
rat mAb against mouse CXCR5.
 
Preparation of Fusion Proteins and mAbs.
 
OX40-Ig was pre-
pared by using protein A purification of supernatant cultures from
a hybridoma expressing this fusion protein (11). Control Ig was
prepared in a similar way. Anti-CD28 mAb was prepared by pro-
tein G purification of supernatants of clone 37.51. These proteins
were sterilized by filtration through 0.2-
 
m
 
m filters, and frozen in
aliquots before use.
 
Experimental Immunizations Where CD28 Signaling Was Restored
by CD28 mAb.
 
Mice expressing soluble CTLA4-Ig or litter-
mate controls were immunized in the intraperitoneal cavity with
50 
 
m
 
g alum-precipitated 4-hydroxy-3-nitrophenyl acetyl (NP)-
KLH resuspended in 200 
 
m
 
l of saline. KLH (Sigma Chemical
Co.) was haptenated as described elsewhere (17). Assuming a
molecular weight of 3 million to KLH, there are 
 
z
 
400 molecules
of NP conjugated to each KLH molecule. Anti-CD28 mAb
(100 
 
m
 
g) was injected intraperitoneally where indicated 24 h after
antigen administration. OX40-Ig or control Ig (100 
 
m
 
g) was in-
jected intraperitoneally on days 1, 2, and 3. Animals were killed
after 9 d, then bled, and their spleens were taken for frozen sec-
tion analysis and flow cytometry.
 
Flow Cytometry.
 
mAbs used for flow cytometry analysis were
FITC-conjugated rat anti–mouse CD4 (Southern Biotechnology),
PE-conjugated rat anti–mouse OX40 (Serotec), biotin-conjugated
rat anti–mouse CD62L (Southern Biotechnology), and rabbit
anti–mouse Burkitt’s lymphoma receptor 1 (BLR1 [CXCR5]).
Secondary step reagents were streptavidin-cychrome (PharMin-
gen) and anti–rabbit PE (Jackson ImmunoResearch Labs).
 
Immunohistology and Quantitative Analysis.
 
Animals were killed
by CO
 
2 
 
asphyxiation, and their spleens were removed, snap-fro-
zen in liquid N
 
2
 
, and stored at 
 
2
 
70
 
8
 
C until use. 5-
 
m
 
m cryostat
sections from these tissues were mounted onto 4-spot glass slides
that were air dried for 1 h, fixed in acetone at 4
 
8
 
C for 20 min,
dried again, and stored in sealed polythene bags at 
 
2
 
20
 
8
 
C.
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Tissue sections were double-stained for IgD (sheep anti–
mouse IgD; Binding Site) with CD3 (KT3), CD4 (GK1.5), or
CD8 (2.43) (American Type Culture Collection). Slides were
stained as described elsewhere (4). In brief, second step reagents
were donkey anti–sheep peroxidase (Binding Site) and biotin-
ylated rabbit anti–rat (DAKO) followed by StreptABComplex al-
kaline phosphatase (DAKO). NP-binding cells were identified
using NP conjugated to rabbit IgG. Secondary Abs were biotiny-
lated swine anti–rabbit and biotinylated rabbit anti–rat. Sheep
anti–mouse IgD was detected using peroxidase-conjugated don-
key anti–sheep Ig (Binding Site).
Substrate for peroxidase was 3-3
 
9
 
 diaminobenzidine (Sigma
Chemical Co.), and for alkaline phosphatase the substrate Naph-
thol AS-MX phosphate and chromogen Fast Blue BB salt/le-
vamisole (Sigma Chemical Co.) were used to block endogenous
alkaline phosphatase activity.
For quantitative analysis, GC size was assessed by counting the
number of graticule intercepts (units) at 400
 
3
 
 magnification of
IgD
 
2
 
 B cell areas within B follicles (15). The numbers of CD3
 
1
 
T cells were counted in each GC.
 
Results
 
Costimulatory Signals through CD28 Upregulate OX40 on
CD3-activated Naive CD4 T Cells.
 
To test for the CD28
dependence of OX40 expression, naive CD62L
 
high
 
 CD4 T
cells were purified from mouse spleens (11) and activated
with anti-CD3 mAb, with and without agonistic CD28
mAb. Unstimulated CD4 cells did not express detectable
levels of OX40 compared with a control isotype-matched
mAb (Fig. 1 a). In addition, the specificity of staining was
checked by cold competition with unlabeled anti-OX40
mAb. This could not inhibit fluorescence on unstimulated
CD4 T cells, indicating undetectable levels of OX40 pro-
tein as assessed by flow cytometry. By 24 h after activation
through CD3, naive CD4 T cells with (Fig. 1 d) and with-
out (Fig. 1 b) agonistic CD28 mAb were equivalently en-
larged in size (data not shown) but it was already clear that
CD28 costimulation augmented OX40 expression (32 vs.
4% positive CD4 T cells). The differences were even more
pronounced after 48 h of culture (compare Fig. 1 e with
Fig. 1 c). Specificity of staining was shown by the capacity
of unlabeled OX40 mAb to inhibit binding of OX40-PE–
specific mAb (data not shown). These results appear to
contradict reports that OX40 expression in vitro
 
 
 
is rela-
tively independent of signaling through CD28 (10, 18).
Because differences in strength of signaling through CD3
with mAb could account for this discrepancy, we went on
to investigate the induction of OX40 expression in vivo.
 
In Vivo OX40 Expression Is Dependent on CD28 Signaling.
 
To test for the CD28 dependence of OX40 expression in
vivo, we compared OX40 induction in CTLA4-Ig tg mice
and nontransgenic littermates. Mice were immunized in
the left footpad with the Th2-inducing antigen, alum-
precipitated, chicken 
 
g
 
-globulin (13), and the draining
popliteal nodes were examined 3 or 7 d later. Levels of
mRNA for OX40 and its ligand, together with the cyto-
kines IL-4 and IFN-
 
g
 
, were quantified in the draining LN
of transgenic and normal littermate mice (Fig. 2). Previous
studies have shown that upregulation of OX40L occurs on
day 2, and IL-4, IFN-
 
g
 
, and OX40 are induced by day 3
(11, 13). There was less mRNA for IL-4, IFN-
 
g
 
, and
OX40 in CTLA4-Ig tg mice compared with control litter-
mates on day 3, although OX40L expression was compara-
ble. In particular, in CTLA4-Ig tg mice, median levels of
day 3 OX40 and IL-4 mRNA were similar to those in day
0 unimmunized controls (data not shown). After 7 d,
CTLA4-Ig tg mice made comparable amounts of IFN-
 
g
 
 as
has been reported elsewhere (8), but there was still much
less mRNA for IL-4 and OX40, and less OX40L in trans-
genic animals. CTLA4-Ig mice immunized with 
 
B
 
.
 
 pertus-
sis
 
,
 
 
 
which evokes IL-4 and IFN-
 
g
 
, and a combination of
IgG1 and IgG2a Abs in normal mice (13) had comparable
levels of IFN-
 
g
 
 at day 3 (data not shown). These data show
there is a relative defect in IL-4 compared with IFN-
 
g
 
,
and this is correlated with deficient OX40 expression in
CTLA4-Ig tg mice. This suggests that in vivo OX40 ex-
pression is CD28 dependent, and that poor OX40 induc-
tion correlates with reduced IL-4 levels.
 
CTLA4-Ig Tg Mice Lack Activated CD4 T Cells that Ex-
press the Chemokine Receptor, CXCR5, and This Subset Is
Increased in CD11c-OX40L Tg Mice.
 
Previously, we re-
ported that ligation of OX40 on CD4 T cells upregulates
mRNA for CXCR5 (11), a chemokine receptor which ap-
pears to direct lymphocytes to B cell follicles (19, 20). Us-
ing mAb and polyclonal rabbit antiserum to CXCR5, we
confirm previous reports (19) that a subset of memory CD4
T cells, which are low in expression of L-selectin (CD62L),
expresses this chemokine receptor (Fig. 3 a). We also found
a proportion of CD62L
 
high
 
 cells expressing CXCR5 as has
been reported in humans (19). This population may repre-
sent an intermediately activated CD4 T cell population.
Alternatively, some CD62L
 
low
 
 cells may revert to a
Figure 1. Costimulation dependence of OX40 expression on CD3-
activated naive CD4 T cells. CD62Lhigh CD4 T cells were stained with
OX40 mAb at different times after activation with CD3 mAb in the ab-
sence (a, b, and c) or presence of agonistic mAb to CD28 (d and e). Flow
gates were set on an isotype-matched control PE-conjugated mAb
(PharMingen).
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CD62L
 
high
 
 phenotype. Mice which constitutively express
OX40L on their DCs (CD11c-OX40L tg mice) are char-
acterized by increased numbers of CD4 T cells in B cell
follicles (12). Here we show that this phenotype is linked
to an expansion of CXCR5
 
1
 
CD62L
 
low
 
 CD4 cells (Fig. 3
b, and Fig. 4 a). In contrast, immunized CTLA4-Ig tg
mice, which lack CD28 costimulation, have some
CD62L
 
low CD4 cells, but these are strikingly deficient in
expression of CXCR5 (Fig. 3 c, and Fig. 4 b). However, if
the CD80/CD86 blockade is bypassed by injection of an
agonistic CD28 mAb, then this subset is rapidly restored
(Fig. 3 d, and Fig. 4 b). These data link CD28 and OX40
signaling with CXCR5 expression on CD4 T cells.
CD4 T Cell CXCR5 Expression and Enhanced Migration
into B Cell Areas in CD11c-OX40L Tg Mice Is Dependent on
CD28 Signaling. CD11c-OX40L tg mice, which consti-
tutively express OX40L on DCs, have increased numbers
of CXCR51CD62Llow CD4 cells and increased numbers of
follicular T cells. To test the CD28 dependence of this
phenotype, we crossed CTLA4-Ig tg mice (heterozygous
for the transgene) with CD11c-OX40L tg mice (heterozy-
gous for the transgene). On average, 25% of the offspring
of this pairing are normal (nontransgenic), 25% are trans-
genic for CTLA4-Ig, 25% transgenic for CD11c-OX40L,
and 25% express both CTLA4-Ig and CD11c-OX40L.
CXCR5 expression was compared in all four groups of an-
imals immunized with alum-precipitated protein antigens.
Normal mice form GCs by day 10 (data not shown) and
have CXCR51CD62Llow CD4 T cells (Fig. 5). CTLA4-Ig
tg mice lack CXCR51 CD62Llow CD4 cells (Fig. 5), and
do not form GCs (7). CD11c-OX40L tg mice have in-
creased CXCR51 CD4 cells (Fig. 5) and form GCs (12).
However, double transgenic mice have the phenotype of
their CTLA4-Ig tg littermates: they lack CXCR5-express-
ing CD62Llow CD4 T cells (Fig. 5), and do not develop
GCs (data not shown). This clearly indicates that the phe-
notype in CD11c-OX40L tg mice requires CD28 signal-
ing, and is consistent with the expression of OX40 being
CD28 dependent in vivo. However, this does not exclude
the possibility that other CD28-dependent signals induce
CXCR5 expression on CD4 T cells.
Rescue of GC Formation by mAb to CD28 in CTLA4-Ig
Tg Mice Is Partially Dependent on OX40 Interactions. The
lack of GC formation in CTLA4-Ig tg mice can be re-
Figure 2. Relative mRNA levels for IFN-g, IL-4, OX40, and OX40L
in the draining LNs of normal (d) and CTLA4-Ig (s) mice at days 3 and
7 after immunization in the footpad with alum-precipitated chicken
g-globulin. Levels are corrected for differences in expression of b-actin.
Average day 3 levels of OX40 and IL-4 in CTLA4-Ig tg mice were simi-
lar to levels in day 0 control unimmunized mice (data not shown).
Figure 3. Expression of CD62L and CXCR5 on gated splenic CD4 T
cells from normal and transgenic mice immunized 10 d previously with
alum-precipitated protein antigens: (a) normal mice; (b) CD11c-OX40L
tg mice; (c) CTLA4-Ig tg mice; and (d) CTLA4-Ig tg mice coinjected
with agonistic mAb to CD28 (100 mg) 1 d after immunization. Staining is
shown from two separate experiments: b should be compared with a, and
d compared with c, as staining for CD62L is slightly different for the two
experiments.
Figure 4. Percentage of gated splenic CD4 T cells that were
CD62Llow, but expressed CXCR5 by flow cytometry 10 d after intraperi-
toneal immunization with alum-precipitated protein antigens: normal lit-
termates for CD11c-OX40L tg mice (r); CD11c-OX40L tg mice (e);
normal littermates for CTLA4-Ig tg mice (d); CTLA4-Ig tg mice (s);
CTLA4-Ig tg mice after coinjection with CD28 mAb (n). Results are
representative of (a) three and (b) eight separate experiments.
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versed by a single injection of agonistic anti-CD28 Ab (Fig.
6 a). These mice develop large GCs, unlike CTLA4-Ig tg
mice given control hamster Ig (data not shown). Produc-
tion of specific IgG Ab is also restored, and there is evi-
dence of affinity maturation (data not shown). Blocking
OX40 interactions with a fusion protein between murine
OX40 and human IgG1 (OX40-Ig) allowed us to test
our hypothesis that the restoration of GC formation by
anti-CD28 treatment is dependent on OX40 signaling.
CTLA4-Ig tg mice were immunized with alum-precipi-
tated protein intraperitoneally, and 1 d later were given
anti-CD28 mAb (100 mg) with either OX40-Ig (100 mg in
three doses on days 1, 2, and 3) or a control Ig fusion pro-
tein. Because CTLA4-Ig tg mice have no GCs, injection of
mAb to CD28 allows accurate timing of their onset. Also,
because CTLA4-Ig tg mice are tolerant to fusion proteins
between human IgG1 and self-proteins, blockade is more
likely to persist and be effective. The presence of CTLA4-Ig,
which binds to CD80 and CD86 on activated B cells, con-
trols for potential artifacts due to OX40-Ig binding to B
cells, independent of its effect on OX40/OX40L blockade.
CTLA4-Ig tg mice treated with anti-CD28 mAb and
control Ig had GCs with a mean size of 30.6 U (see Mate-
rials and Methods; Fig. 6 a) with 67.3 T cells per GC (Fig.
6 b). In marked contrast, CTLA4-Ig tg mice treated with
OX40-Ig had much smaller but not absent GCs with a
mean size of 8.1 U (Fig. 6 a), and a mean number of T cells
per GC of 18.7 (Fig. 6 b). Although GC size was dimin-
ished in OX40-Ig–injected mice, the extrafollicular anti-
NP plasma cell responses were consistently increased (data
not shown). These data link CD4 T cell OX40 signaling
with GC development, but not with the extrafollicular
plasma cell response.
Discussion
We have investigated the sequence of molecular instruc-
tions that control CD4 T cell migration and differentiation
to provide GC T cell help. We recently published evidence
that OX40 signaling was linked with induction of IL-4 ex-
pression (11), and studies in humans have yielded a similar
conclusion (10). We also found that OX40 ligation was
linked with upregulation of CXCR5 on CD4 T cells, a
chemokine receptor linked with lymphocyte migration to
B cell areas. This idea was supported by the phenotype of
CD11c-OX40L tg mice, which have increased CD4 T cell
numbers within GCs (12). CD28-deficient mice are also
deficient in their capacity to provide B cell help: they have
a relatively selective deficit in Th2 development (8), and
lack GCs (7, 21). In keeping with the idea that CXCR51
CD4 cells are implicated in GC development, we report
here that CTLA4-Ig tg mice have a selective deficit in
these cells. In contrast, CD11c-OX40L tg mice, which
have greatly increased CD4 T cells in B cell areas, have
the opposite phenotype, with an increased proportion of
CXCR5 CD41CD62Llow cells.
To understand the relationship between CD28 and
OX40 signaling in development of CXCR51 CD4 T cells
Figure 5. CD28 dependence of CXCR5 expression in CD11c-
OX40L tg mice. Percentage of CD4 T cells that were CD62Llow, but ex-
pressed CXCR5 10 d after intraperitoneal immunization with alum-pre-
cipitated protein antigens: normal littermates (d); CTLA4-Ig tg mice
(s); CD11c-OX40L tg mice (e); double transgenic mice coexpressing
CD11c-OX40L and CTLA4-Ig tg (u). Data are shown from one litter
resulting from crossing CTLA4-Ig tg and CD11c-OX40L tg mice, and
are representative of two separate experiments.
Figure 6. GC size and average
number of T cells per GC in mice
immunized 9 d previously with
100 mg alum-precipitated protein
antigen. Results are shown for
normal littermate controls (d);
CTLA4-Ig tg mice treated with
anti-CD28 mAb and either a con-
trol Ig fusion protein (control-Ig,
100 mg; n) or OX40-Ig (100 mg;
X). Results show the mean GC
size (a) and T cells/GC (b). In
each mouse, 20 consecutive GC
areas were measured, and the
numbers of individual CD3 cells
within GCs were counted. Re-
sults are representative of two sep-
arate experiments.
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and GCs, we investigated the CD28 dependence of OX40
expression. Although it has been reported that OX40 ex-
pression in vitro is independent of CD28 costimulation
(10, 18), in our hands we found that levels of OX40 in
vitro and in vivo were greatly augmented by CD28 signal-
ing. We hypothesized that poor expression of OX40 in
CD28-deficient mice was linked with the lack of GC de-
velopment (7, 8). To test this, we acutely reversed the
CD28 signaling defect by injection of agonistic CD28
mAb. GCs reappear in Ab-treated mice, and this is corre-
lated with the appearance of CXCR51CD62Llow CD4 T
cells. If, however, OX40 interactions were blocked by
OX40-Ig, GC formation was greatly reduced, although
significantly the extrafollicular plasma cell response was
augmented (data not shown). These data strongly support
the idea that CD28-costimulated CD4 T cells primed in
the outer T zone by DCs upregulate OX40, which allows
them to respond to OX40L expressed by either CD40-
activated DCs (12, 22) or activated B cells (23). This sequen-
tial signal then activates a program of events that includes
upregulation of IL-4, CXCR5 expression, and migration
into follicles to help B cells form GCs. This model predicts
that the enhanced accumulation of CD4 T cells in B cell
follicles in CD11c-OX40L tg mice would be dependent on
CD28 signaling, which indeed proved to be the case in our
study.
Although our data implicate ligation of OX40 on T cells
in CD4 migration into B follicles, injection of OX40-Ig
reduced rather than abolished GC formation. Preliminary
experiments show OX40-deficient mice can develop GCs
albeit at a slower tempo (our unpublished observations), in-
dicating that other molecules can substitute for OX40.
CD70 (CD27L), whose receptor is expressed on resting
CD4 T cells (24), is a good candidate, as in vitro it has sim-
ilar effects on CD4 T cell differentiation and, like OX40L,
is expressed on both CD40-activated B cells and DCs (our
unpublished observations). This situation is analogous to
CD80 and CD86, which can both costimulate T cells
through CD28, but perhaps because of temporal differ-
ences in expression, exert subtle differences on T cell im-
mune responses.
Our model of the role of OX40 in CD4 T cell differen-
tiation is different from that proposed elsewhere (23, 25),
which suggests that ligation of B cell OX40L by CD4 T
cell OX40 promotes the extrafollicular plasma cell re-
sponse, but does not influence GC development. In the in
vivo experiments described (25), a polyclonal rabbit anti-
serum to OX40 was used to block OX40/OX40L inter-
actions. We speculate that this antiserum might signal
OX40-expressing CD4 T cells to migrate into B folli-
cles, as in the CD11c-OX40L tg mice (12). In our ex-
periments, injection of OX40-Ig would allow signaling
through B cell OX40L and the development of the ex-
trafollicular plasma cell response, but by blocking OX40
ligation of CD4 T cells, would inhibit T cell migration
and reduce GC formation.
Much controversy exists in the literature concerning the
role of CD28 signaling in immunosuppression strategies. In
general, mice rendered deficient from birth in CD28 sig-
naling, by either gene deletion of CD28 (6) or constitutive
expression of CTLA4-Ig (7), make surprisingly normal im-
mune responses. They can reject grafts (26; and our unpub-
lished observations), resist intracellular infections such as
Leishmania (27), and mount many normal viral immune re-
sponses (6, 28). The one consistent immune deficit is the
capacity to make B cell GCs (7, 21), and this is linked to
selective deficiency in Th2 responses (8, 29). However, if
CD28 is blocked acutely in normal mice by injecting
CTLA4-Ig, very different results can be obtained (30).
CD4 T cell responsiveness is regulated by a balance be-
tween CD28 (positive) and CTLA4 (negative) signaling
(26), and the differences observed with acute and chronic
blockade of CD28 by CTLA4-Ig could be due to individ-
ual T cells tuning their responsiveness to the costimulatory
environment in which they mature. In this paper, we
found that acute reversal of CD28 signaling in CTLA4-Ig
tg mice led to massive GC formation, which is in keeping
with the idea that CD4 T cells in these mice are hyperre-
sponsive when CD28 blockade is reversed (31, 32). How-
ever, our data also provide a potential explanation for why
the timing of CD28 blockade may have very different con-
sequences for the subsequent immunological response. We
have shown that CD28 signaling is permissive for other co-
stimulatory signals such as OX40. We speculate that delay-
ing CD28 blockade allows OX40 signaling to occur at the
onset of immune responses, which allows Th2 CD4 T cells
to develop (30, 33), resulting in less damaging autoimmune
and transplant responses. It could also explain why block-
ing CD86 aggravates experimental allergic encephalitis, a
model in which pathology is largely Th1 mediated (34).
CD86 is constitutively expressed on DCs and could pro-
vide crucial early CD28 signals required for OX40 expres-
sion.
Evidence that OX40 blockade modifies the course of in-
flammatory disorders (35, 36) indicates roles for OX40
other than in development of GCs. In addition to its ex-
pression on activated DCs and B cells, OX40L is expressed
on vascular endothelium (37). An intriguing possibility is
that ligation of OX40 here is involved in recruitment of
activated T cells to inflammatory sites. Both CTLA4-Ig
(38) and OX40-Ig (35) abrogate susceptibility to experi-
mental allergic encephalitis. However, CTLA4-Ig does not
block priming of encephalogenic T cells (38). This might
be explained if CTLA4-Ig blocked OX40 expression,
hence inhibiting migration into the central nervous system.
Therefore, the effects of OX40 ligation may depend on the
context in which CD4 T cells find themselves.
 o
n
 August 15, 2008 
w
w
w
.jem.org
D
ow
nloaded from
 
 Published October 18, 1999
1121 Walker et al.
References
1. Jacob, J., R. Kassir, and G. Kelsoe. 1991. In situ studies of
the primary immune response to (4-hydroxy-3-nitrophe-
nyl)acetyl. I. The architecture and dynamics of responding
cell populations. J. Exp. Med. 173:1165–1176.
2. Liu, Y.J., J. Zhang, P.J. Lane, E.Y. Chan, and I.C. MacLen-
nan. 1991. Sites of specific B cell activation in primary and
secondary responses to T cell-dependent and T cell-indepen-
dent antigens. Eur. J. Immunol. 21:2951–2962.
3. MacLennan, I.C.M., A. Gulbranson-Judge, K.M. Toellner,
M. Casamayor-Palleja, E. Chan, D.M.Y. Sze, S.A. Luther,
and H.A. Orbea. 1997. The changing preference of T and B
cells for partners as T-dependent antibody responses develop.
Immunol. Rev. 156:53–66.
4. Gulbranson-Judge, A., and I. MacLennan. 1996. Sequential
antigen-specific growth of T cells in the T zones and follicles
in response to pigeon cytochrome C. Eur. J. Immunol. 26:
1830–1837.
5. Han, S., K. Hathcock, B. Zheng, T.B. Kepler, R. Hodes,
and G. Kelsoe. 1995. Cellular interaction in germinal centers.
Roles of CD40 ligand and B7-2 in established germinal cen-
ters. J. Immunol. 155:556–567.
6. Shahinian, A., K. Pfeffer, K.P. Lee, T.M. Kundig, K. Kishi-
hara, A. Wakeham, K. Kawai, P.S. Ohashi, C.B. Thompson,
and T.W. Mak. 1993. Differential T cell costimulatory re-
quirements in CD28-deficient mice. Science. 261:609–612.
7. Lane, P., C. Burdet, S. Hubele, D. Scheidegger, U. Müller,
F. McConnell, and M. Kosco-Villbois. 1994. B cell function
in mice transgenic for mCTLA4-Hg1: lack of germinal cen-
ters correlated with poor affinity maturation and class switch-
ing despite normal priming of CD41 T cells. J. Exp. Med.
179:819–830.
8. Lenschow, D.J., K.C. Herold, L. Rhee, B. Patel, A. Koons,
H.-Y. Qin, E. Fuchs, B. Singh, C.B. Thompson, and J.A.
Bluestone. 1996. CD28/B7 regulation of Th1 and Th2 sub-
sets in the development of autoimmune diabetes. Immunity.
5:285–293.
9. Manickasingham, S.P., S.M. Anderton, C. Burkhart, and
D.C. Wraith. 1998. Qualitative and quantitative effects of
CD28/B7-mediated costimulation on naive T cells in vitro.
J. Immunol. 161:3827–3835.
10. Ohshima, Y., L.P. Yang, T. Uchiyama, Y. Tanaka, P. Baum,
M. Sergerie, P. Hermann, and G. Delespesse. 1998. OX40
costimulation enhances interleukin-4 (IL-4) expression at
priming and promotes the differentiation of naive human
CD41 T cells into high IL-4-producing effectors. Blood. 92:
3338–3345.
11. Flynn, S., K.-M. Toellner, C. Raykundalia, M. Goodall, and
P. Lane. 1998. CD4 T cell cytokine differentiation: the B cell
activation molecule, OX40 ligand, instructs CD4 T cells to
express interleukin 4 and upregulates expression of the
chemokine receptor, Blr-1. J. Exp. Med. 188:297–304.
12. Brocker, T., A. Gulbranson-Judge, S. Flynn, M. Riedinger,
C. Raykundalia, and P. Lane. 1999. CD4 T cell traffic con-
trol: in vivo evidence that ligation of OX40 on CD4 T cells
by OX40-ligand expressed on dendritic cells leads to the ac-
cumulation of CD4 T cells into B follicles. Eur. J. Immunol.
29:1610–1616.
13. Toellner, K., S. Luther, D.M.-Y. Sze, R.K.-W. Choy, D.R.
Taylor, I.C.M. MacLennan, and H. Acha-Orbea. 1998. T
helper 1 (Th1) and Th2 characteristics start to develop during
T cell priming and are associated with an immediate ability to
induce immunoglobulin class switching. J. Exp. Med. 187:
1193–1204.
14. Svetic, A., F.D. Finkelman, Y.C. Jian, C.W. Dieffenbach,
D.E. Scott, K.F. McCarthy, A.D. Steinberg, and W.C.
Gause. 1991. Cytokine gene-expression after in vivo primary
immunization with goat antibody to mouse IgD antibody. J.
Immunol. 147:2391–2397.
15. Weibel, E.R. 1963. Principles and methods for the morpho-
metric study of the lung and other organs. Lab. Invest. 12:
131–155.
16. Schmidt, K.N., C.W. Hsu, C.T. Griffin, C.C. Goodnow,
and J.G. Cyster. 1998. Spontaneous follicular exclusion of
SHP1-deficient B cells is conditional on the presence of
competitor wild-type B cells. J. Exp. Med. 187:929–937.
17. Nossal, G.J., and M. Karvelas. 1990. Soluble antigen abro-
gates the appearance of anti-protein IgG1-forming cell pre-
cursors during primary immunization. Proc. Natl. Acad. Sci.
USA. 87:1615–1619.
18. Gramaglia, I., A.D. Weinberg, M. Lemon, and M. Croft.
1998. Ox-40 ligand: a potent costimulatory molecule for sus-
taining primary CD4 T cell responses. J. Immunol. 161:6510–
We are very grateful to Jason Cyster for providing the polyclonal CXCR5-specific antiserum and for his
many helpful comments on the manuscript. We would also like to thank Ian MacLennan, David Sansom,
Matt Cook, Kai Toellner, and Graham Anderson for reading the manuscript and making many helpful sug-
gestions. These experiments could not have been done without the expert help of the staff of the Birming-
ham University Animal Facility (BMSU).
This work was supported by grants from the Wellcome Trust to P. Lane. S. Flynn is supported by a Medical
Research Council Ph.D. studentship. T. Brocker is supported by the Deutsche Forschungsgemeinschaft
Leibniz-Program (to M. Reth).
Address correspondence to Peter Lane, Medical Research Council Centre for Immune Regulation, Bir-
mingham Medical School, Vincent Dr., Birmingham B15 2TT, UK. Phone: 44-121-414-4078; Fax: 44-
121-414-3599; E-mail: p.j.l.lane@bham.ac.uk
Submitted: 15 April 1999 Revised: 21 June 1999 Accepted: 10 August 1999
 o
n
 August 15, 2008 
w
w
w
.jem.org
D
ow
nloaded from
 
 Published October 18, 1999
1122 Compromised OX40 Function in CD28-deficient Mice
6517.
19. Förster, R., T. Emrich, E. Kremmer, and M. Lipp. 1994. Ex-
pression of the G-protein–coupled receptor BLR1 defines
mature, recirculating B cells and a subset of T-helper mem-
ory cells. Blood. 84:830–840.
20. Förster, R., A.E. Mattis, E. Kremmer, E. Wolf, G. Brem, and
M. Lipp. 1996. A putative chemokine receptor, BLR1, di-
rects B cell migration to defined lymphoid organs and spe-
cific anatomic compartments of the spleen. Cell. 87:1037–
1047.
21. Ferguson, S.E., S. Han, G. Kelsoe, and C.B. Thompson.
1996. CD28 is required for germinal center formation. J. Im-
munol. 156:4576–4581.
22. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Mal-
iszewski, and G. Delespesse. 1997. Expression and function
of OX40 ligand on human dendritic cells. J. Immunol. 159:
3838–3848.
23. Stüber, E., M. Neurath, D. Calderhead, H.P. Fell, and W.
Strober. 1995. Cross-linking of OX40 ligand, a member of the
TNF/NGF cytokine family, induces proliferation and differ-
entiation in murine splenic B cells. Immunity. 2:507–521.
24. Gravestein, L.A., B. Blom, L.A. Nolten, E. Devries, G.
Vanderhorst, F. Ossendorp, J. Borst, and W.A.M. Loenen.
1993. Cloning and expression of murine CD27: comparison
with 4-1BB, another lymphocyte-specific member of the
nerve growth factor receptor family. Eur. J . Immunol. 23:
943–950.
25. Stüber, E., and W. Strober. 1996. The T cell–B cell interac-
tion via OX40–OX40L is necessary for the T cell–dependent
humoral immune response. J. Exp. Med. 183:979–989.
26. Lenschow, D.J., T.L. Walunas, and J.A. Bluestone. 1996.
CD28/B7 system of T cell costimulation. Annu. Rev. Immu-
nol. 14:233–258.
27. Brown, D.R., J.M. Green, N.H. Moskowitz, M. Davis, C.B.
Thompson, and S.L. Reiner. 1996. Limited role of CD28-
mediated signals in T helper subset differentiation. J. Exp.
Med. 184:803–810.
28. Zimmermann, C., P. Seiler, P. Lane, and R.M. Zinkernagel.
1997. Antiviral immune responses in CTLA4 transgenic
mice. J. Virol. 71:1802–1807.
29. King, C.L., X.L. Jia, C.H. June, R. Abe, and K.P. Lee. 1996.
CD28-deficient mice generate an impaired Th2 response to
Schistosoma mansoni infection. Eur. J. Immunol. 26:2448–2455.
30. Sayegh, M.H., E. Akalin, W.W. Hancock, M.E. Russell,
C.B. Carpenter, P.S. Linsley, and L.A. Turka. 1995. CD28-
B7 blockade after alloantigenic challenge in vivo inhibits Th1
cytokines but spares Th2. J. Exp. Med. 181:1869–1874.
31. Ronchese, F., B. Hausmann, S. Hubele, and P. Lane. 1994.
Mice transgenic for a soluble form of murine CTLA-4 show
enhanced expansion of antigen-specific CD41 T cells and
defective antibody production in vivo. J. Exp. Med. 179:809–
817.
32. Lane, P., C. Haller, and F. McConnell. 1996. Evidence that
induction of tolerance in vivo involves active signaling via a
B7 ligand-dependent mechanism: CTLA4-Ig protects Vb81
T cells from tolerance induction by the superantigen staphy-
lococcal enterotoxin B. Eur. J. Immunol. 26:858–862.
33. Lenschow, D.J., S.C. Ho, H. Sattar, L. Rhee, G. Gray, N.
Nabavi, K.C. Herold, and J.A. Bluestone. 1995. Differential
effects of anti–B7-1 and anti–B7-2 monoclonal antibody on
the development of diabetes in the nonobese diabetic mouse.
J. Exp. Med. 181:1145–1155.
34. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S.
Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H.
Glimcher. 1995. B7-1 and B7-2 costimulatory molecules ac-
tivate differentially the Th1/Th2 developmental pathways:
application to autoimmune disease therapy. Cell. 80:707–718.
35. Weinberg, A.D., A.T. Vella, and M. Croft. 1998. OX-40: life
beyond the effector T cell stage. Semin. Immunol. 10:471–480.
36. Higgins, L.M., S.A. McDonald, N. Whittle, N. Crockett,
J.G. Shields, and T.T. MacDonald. 1999. Regulation of T
cell activation in vitro and in vivo by targeting the OX40-
OX40 ligand interaction: amelioration of ongoing inflamma-
tory bowel disease with an OX40-IgG fusion protein, but
not with an OX40 ligand-IgG fusion protein. J. Immunol.
162:486–493.
37. Imura, A., T. Hori, K. Imada, T. Ishikawa, Y. Tanaka, M.
Maeda, S. Imamura, and T. Uchiyama. 1996. The human
OX40/gp34 system directly mediates adhesion of activated T
cells to vascular endothelial cells. J. Exp. Med. 183:2185–
2191.
38. Cross, A.H., T.J. Girard, K.S. Giacoletto, R.J. Evans, R.M.
Keeling, R.F. Lin, J.L. Trotter, and R.W. Karr. 1995. Long-
term inhibition of murine experimental autoimmune en-
cephalomyelitis using CTLA4-Fc supports a key role for
CD28 costimulation. J. Clin. Invest. 95:2783–2789.
 o
n
 August 15, 2008 
w
w
w
.jem.org
D
ow
nloaded from
 
 Published October 18, 1999
